Lysergic Acid Diethylamide (LSD) in Palliative Care

NCT05883540 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Palliative Care
Pain
Anxiety
Depression
Demoralization
Psychological Distress
Quality of Life
Caregiver Burden
Fear of Death
Existential Distress

Interventions

DRUG: Lysergic Acid Diethylamide Tartrate
DRUG: Lysergic Acid Diethylamide Tartrate

Sponsor

University Hospital, Basel, Switzerland

Collaborators

[object Object]
[object Object]
[object Object]